Bi Asset Management Fondsmaeglerselskab A Neurocrine Biosciences Inc Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $8.88 Billion
- Q1 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 4,937 shares of NBIX stock, worth $620,729. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,937
Previous 12,322
59.93%
Holding current value
$620,729
Previous $1.68 Million
67.54%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.25 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$696 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$611 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$336 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...